The concept of the GLOW Blend arises from decades of research into individual signaling peptides. GHK-Cu was first identified in biological plasma samples in the 1970s and later studied for gene regulation and matrix remodeling activity. BPC-157 was synthesized in the 1990s as a gastric protein fragment analog and has since been researched for angiogenic and structural processes. TB-500, derived from thymosin beta-4, traces its research lineage to thymus peptide studies in the 1960s and is recognized for its effects on molecular migration and angiogenesis. Combined, these peptides represent a convergence of experimental research lines.
Peptides
GLOW
$99.00
The GLOW Blend combines three synthetic peptides studied for their roles in molecular signaling and pathway dynamics: GHK-Cu, BPC-157, and TB-500. Together, these peptides are investigated for their influence on angiogenesis, extracellular matrix remodeling, and systemic signaling pathways. In laboratory and preclinical models, the combination provides a platform for exploring synergistic effects in matrix integrity, vascular formation, and molecular resilience.




Reviews
There are no reviews yet.